Role of mitogen‐activated protein kinase family in serum‐induced leukaemia inhibitory factor and interleukin‐6 secretion by bone marrow stromal cells

• Published in: British journal of pharmacology 2002-08, Vol.136 (7), p.975-984
• Main Authors: Nakao, Takafumi, Kim, Shokei, Ohta, Kensuke, Kawano, Hitomi, Hino, Masayuki, Miura, Katsuyuki, Tatsumi, Noriyuki, Iwao, Hiroshi
• Format: Article
• Language: English
• Subjects: Analysis of Variance; Biological and medical sciences; Blood; Blotting, Western; Bone Marrow Cells - metabolism; Bone marrow stromal cells; Cell Line; Central nervous system; Central neurotransmission. Neuromudulation. Pathways and receptors; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Fundamental and applied biological sciences. Psychology; Growth Inhibitors - biosynthesis; haematopoiesis; Humans; Interleukin-6 - biosynthesis; interleukin‐6; JNK Mitogen-Activated Protein Kinases; leukaemia inhibitory factor; Leukemia Inhibitory Factor; Lymphokines - biosynthesis; MAPK; Mitogen-Activated Protein Kinases - antagonists & inhibitors; Mitogen-Activated Protein Kinases - genetics; Mitogen-Activated Protein Kinases - metabolism; p38 Mitogen-Activated Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - metabolism; Stromal Cells - metabolism; Vertebrates: blood, hematopoietic organs, reticuloendothelial system; Vertebrates: nervous system and sense organs
• ISSN: 0007-1188; 1476-5381
• DOI: 10.1038/sj.bjp.0704797

In the haematopoietic microenvironment, bone marrow stromal cells play an important role in regulating haematopoiesis by expressing various cytokines, including leukaemia inhibitory factor (LIF) and interleukin‐6 (IL‐6). However, the intracellular signal that regulates cytokine secretion in bone marrow stromal cells has not been determined. The aim of this study was to evaluate the role of mitogen‐activated protein kinase (MAPK) family in serum‐induced secretion of LIF and IL‐6 by bone marrow stromal cells. Transformed human bone marrow stromal cells (HS‐5) were stimulated with foetal calf serum (FCS) to produce LIF and IL‐6. FCS also induced activation of extracellular signal‐regulated kinase (ERK), p38 MAPK and c‐Jun NH2‐terminal kinase (JNK). Both PD98059 (MAPK/ERK kinase inhibitor) and SB203580 (p38 MAPK inhibitor) attenuated FCS‐induced LIF protein production and gene expression. SB203580 decreased IL‐6 production and gene expression, but PD98059 had no effect on IL‐6 production and gene expression. Expression of a dominant‐negative mutant form of JNK1 that blocked FCS‐induced JNK activity had no effect on protein production and gene expression of these cytokines. These findings demonstrate that both ERK and p38 MAPK are involved in FCS‐induced LIF secretion, whereas only p38 MAPK is important for IL‐6 secretion, and that FCS‐induced activation of JNK has no effect on the production of LIF and IL‐6. We conclude that, in spite of their similar biological effects, they are differentially regulated at the level of MAPK activity in bone marrow stromal cells. British Journal of Pharmacology (2002) 136, 975–984. doi:10.1038/sj.bjp.0704797